Shalby Ltd
Mon 5/05/2025,15:57:54 | NSE : SHALBY
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 187.71
Previous Close
₹ 187.71
Volume
98188
Mkt Cap ( Rs. Cr)
₹2011.14
High
₹ 189.16
Low
₹ 185.70
52 Week High
₹ 325.00
52 Week Low
₹ 180.35
Book Value Per Share
₹ 93.25
Dividend Yield
0.64
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Shalby Ltd
Your Vote -
Buy
65.52%
Hold
10.34%
Sell
24.14%
65.52%
29 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
186.20
71
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
71
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Shalby Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Shalby has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Shalby - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Shalby - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Shalby - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Shalby - Updates
-
Shalby - Disclosure Under Reg. 31(4) Of SEBI (SAST), Regulations, 2011
-
Shalby - General Updates
-
Shalby - Allotment Of Equity Shares By Wholly Owned Subsidiary, Shalby Medtech Ltd To Shalby Ltd
-
Shalby - Termination Of Franchise Agreement, Ranchi
-
Shalby - Rescission/termination(s)
-
Shalby - Trading Window-XBRL
-
Shalby - Trading Window
-
Shalby - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Shalby - Announcement under Regulation 30 (LODR)-Credit Rating
-
Shalby - Credit Rating
-
Shalby - Receipt Of Hand Transplant Approval
-
Shalby - Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
-
Shalby - Copy of Newspaper Publication
-
Shalby - Analysts/Institutional Investor Meet/Con. Call Updates
-
Shalby - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Shalby - Notice Of Shareholders Meetings-XBRL
-
Shalby - Shareholders meeting
-
Shalby - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Shalby - Updates
-
Shalby - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
-
Shalby - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Req
-
Shalby - Action(s) taken or orders passed
-
Shalby
-
Shalby
-
Shalby
-
Shalby provides $9.45 m letter of credit for US arm
Key fundamentals
Evaluate the intrinsic value of Shalby Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 1176.2 | 995.819 | 948.029 | 885.149 | 862.467 |
| Liabilities | 1176.2 | 995.819 | 948.029 | 885.149 | 862.467 |
| Equity | 107.413 | 107.31 | 108.01 | 108.01 | 108.01 |
| Gross Profit | 177.569 | 142.157 | 130.014 | 86.126 | 81.506 |
| Net Profit | 103.845 | 80.808 | 69.806 | 42.881 | 27.972 |
| Cash From Operating Activities | 139.772 | 164.528 | 100.98 | 82.446 | 57.087 |
| NPM(%) | 12.51 | 11.41 | 10.78 | 10.24 | 5.78 |
| Revenue | 829.682 | 708.017 | 647.16 | 418.669 | 483.886 |
| Expenses | 652.113 | 565.86 | 517.146 | 332.543 | 402.38 |
| ROE(%) | 10.31 | 8.02 | 6.93 | 4.25 | 2.77 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 19 Sep 2024 | 1.2 | 12 | 0.64 | 267.1 |
| 08 Aug 2023 | 1.2 | 12 | 0.64 | 137.6 |
| 19 Sep 2022 | 1 | 10 | 0.64 | 104 |
| 17 Sep 2021 | 1 | 10 | 0.64 | 138.45 |
| 04 Sep 2020 | 0.5 | 5 | 0.64 | 70 |
| 16 Aug 2019 | 0.5 | 5 | 0.64 | 130.55 |
Peers
Other companies within the same industry or sector that are comparable to Shalby Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 842.00 | 1.23 | 11.88 | 106.30 | 1321.50 | 1.37 |
| Lotus Eye Hospital and Institute Ltd | 75.09 | -7.85 | 312.88 | 387.33 | 14.01 | 0.67 |
| Vaishali Pharma Ltd | 12.09 | -2.58 | 403.00 | 199.65 | 2.76 | 0.00 |
| Astec Lifesciences Ltd | 673.15 | 0.56 | 0.00 | 365.22 | -687.11 | 0.00 |
Company Info
The Company was originally incorporated as Shalby Hospital Private Limited on August 30, 2004 at Ahmedabad, Gujarat, India, as a private limited company under the Companies Act, 1956. Subsequently, the Company was converted to a public limited company and a fresh certificate of incorporation consequent upon change of name on conversion to a public limited company was issued by the RoC on May 15, 2006 in the name of Shalby Hospital Public Limited. The name of the Company was subsequently changed to Shalby Hospitals Limited, and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on July 26, 2006. Thereafter, the name of the Company was changed to Shalby Limited, and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on February 13, 2008. The change to the name of our Company from Shalby Hospital Private Limited to Shalby Hospital Public Limited was undertaken upon conversion of the Company from a private limited company to a public limited company. Subsequent changes to the name of the Company to Shalby Hospitals Limited and Shalby Limited were undertaken to explore other activities as mentioned in the main objects of the Memorandum of Association. MAJOR EVENTS AND MILESTONES OF OUR COMPANY 2007 -Established and commenced operations of our first multi-specialty hospital, SG Shalby, at Sarkhej Gandhinagar Highway in Ahmedabad 2013 -Krishna Shalby commences operations -Shalby Vapi commences operations 2015 -Shalby Jabalpur commences operations 2016 -Shalby Indore commences operations -Executed a memorandum of understanding with ZH Private Limited to manage and operate Zynova Shalby -Executed an O&M agreement with Kamesh Hospital to commence operations of Shalby Mohali 2017 -Entered into an agreement with Bait Al Batterjee Medical Company LLC, Dubai, to provide outpatient orthopaedics and spine surgeries AWARDS AND ACCREDITATIONS 2017 -Best CSR Initiative in Healthcare Award -The Best Hospital for Medical Tourism of Gujarat Award 2016 -The Best Medical Tourism Centre of Gujarat Award -Gujarat Ratna Award 2015 -Emerging Tertiary Care Hospital of the Year Award 2014 -Best Multi-specialty Hospital - Metro -Company of the Year Award (In recognition of valuable contribution towards healthcare) -Hercules Award 2013 -Healthcare Service Provider Company of the Year Award (In the category for companies generating annual revenue below ?5,000 million) 2012 -Best Medium Enterprise Award 2011 -FICCI Healthcare Operational Excellence Award 2010 -Rajiv Gandhi National Quality Award. 2018 -"Shalby Bagged Medical Value Travel Specialist Hospital Award 2018 for Orthopaedics. 2019 -Shalby Hospitals conferred with the best hospital for Medical Tourism in Gujarat Award. -Shalby Hospitals bestowed with best IT enabled Hospital Award 2019. 2020 -Shalby Bestowed With The Best Hospital For Patient Care Award.-Inauguration of First Orthopedic & Joint Replacement Franchise at Udaipur. 2021 -Shalby Hospitals Conferred with "Best Medical Tourism Centre of Gujarat Award. 2022 -Shalby Hospitals awarded as the BEST ORTHOPEDIC HOSPITAL in India by The Economic Times. 2023 -Company Received License to sell knee and Hip implants in Indonesia. 2024 -Shalby Multispecialty Hospital honored with Prestigious Best Hospital Chain of the Year (West) by Economic Times Healthcare Awards 2024. -"Strategic investment in Healers Hospital Private Limited (Healers Hospital) with an acquisition of 100% equity stake".
The Company was originally incorporated as Shalby Hospital Private Limited on August 30, 2004 at Ahmedabad, Gujarat, India, as a private limited company under the Companies Act, 1956. Subsequently, the Company was converted to a public limited company and a fresh certificate of incorporation consequent upon change of name on conversion to a public limited company was issued by the RoC on May 15, 2006 in the name of Shalby Hospital Public Limited. The name of the Company was subsequently changed to Shalby Hospitals Limited, and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on July 26, 2006. Thereafter, the name of the Company was changed to Shalby Limited, and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on February 13, 2008. The change to the name of our Company from Shalby Hospital Private Limited to Shalby Hospital Public Limited was undertaken upon conversion of the Company from a private limited company to a public limited company. Subsequent changes to the name of the Company to Shalby Hospitals Limited and Shalby Limited were undertaken to explore other activities as mentioned in the main objects of the Memorandum of Association. MAJOR EVENTS AND MILESTONES OF OUR COMPANY 2007 -Established and commenced operations of our first multi-specialty hospital, SG Shalby, at Sarkhej Gandhinagar Highway in Ahmedabad 2013 -Krishna Shalby commences operations -Shalby Vapi commences operations 2015 -Shalby Jabalpur commences operations 2016 -Shalby Indore commences operations -Executed a memorandum of understanding with ZH Private Limited to manage and operate Zynova Shalby -Executed an O&M agreement with Kamesh Hospital to commence operations of Shalby Mohali 2017 -Entered into an agreement with Bait Al Batterjee Medical Company LLC, Dubai, to provide outpatient orthopaedics and spine surgeries AWARDS AND ACCREDITATIONS 2017 -Best CSR Initiative in Healthcare Award -The Best Hospital for Medical Tourism of Gujarat Award 2016 -The Best Medical Tourism Centre of Gujarat Award -Gujarat Ratna Award 2015 -Emerging Tertiary Care Hospital of the Year Award 2014 -Best Multi-specialty Hospital - Metro -Company of the Year Award (In recognition of valuable contribution towards healthcare) -Hercules Award 2013 -Healthcare Service Provider Company of the Year Award (In the category for companies generating annual revenue below ?5,000 million) 2012 -Best Medium Enterprise Award 2011 -FICCI Healthcare Operational Excellence Award 2010 -Rajiv Gandhi National Quality Award. 2018 -"Shalby Bagged Medical Value Travel Specialist Hospital Award 2018 for Orthopaedics. 2019 -Shalby Hospitals conferred with the best hospital for Medical Tourism in Gujarat Award. -Shalby Hospitals bestowed with best IT enabled Hospital Award 2019. 2020 -Shalby Bestowed With The Best Hospital For Patient Care Award.-Inauguration of First Orthopedic & Joint Replacement Franchise at Udaipur. 2021 -Shalby Hospitals Conferred with "Best Medical Tourism Centre of Gujarat Award. 2022 -Shalby Hospitals awarded as the BEST ORTHOPEDIC HOSPITAL in India by The Economic Times. 2023 -Company Received License to sell knee and Hip implants in Indonesia. 2024 -Shalby Multispecialty Hospital honored with Prestigious Best Hospital Chain of the Year (West) by Economic Times Healthcare Awards 2024. -"Strategic investment in Healers Hospital Private Limited (Healers Hospital) with an acquisition of 100% equity stake".
Read More
Parent Organisation
Shalby Ltd.
Founded
30/08/2004
Managing Director
Dr.Vikram Shah
NSE Symbol
SHALBYEQ
FAQ
The current price of Shalby Ltd is ₹ 186.20.
The 52-week high for Shalby Ltd is ₹ 189.16 and the 52-week low is ₹ 185.70.
The market capitalization of Shalby Ltd is currently ₹ 2011.14. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Shalby Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Shalby Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Shalby Ltd shares.
The CEO of Shalby Ltd is Dr.Vikram Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
